what is glp-1 agonist Non-insulin injectable antidiabetic drugs - agonists and amylinomimetics GLP-1 receptor agonists show promise
Description
Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity (STEP 3)
New England Journal of Medicine, 393 (11), 10651076
Adv Exp Med Biol (2019) 1184:187203
N., Shukla P., Elased K
